KEYNOTE ADDRESS The role of vertebral augmentation in multiple myeloma: International Myeloma Working Group Consensus Statement
نویسندگان
چکیده
MA Hussein, FD Vrionis, R Allison, J Berenson, S Berven, E Erdem, S Giralt, S Jagannath, RA Kyle, S LeGrand, R Pflugmacher, N Raje, SV Rajkumar, L Randall, D Roodman, D Siegel, R Vescio, J Zonder and BGM Durie on behalf of the International Myeloma Working Group Department of Hematologic Malignancies, H Lee Moffitt Cancer Center, Tampa, FL, USA; Department of Neuro-Oncology, H Lee Moffitt Cancer Center, Tampa, FL, USA; Department of Radiation Oncology, Brody School of Medicine at ECU, Greenville, NC, USA; Department of Hematology/Medical Oncology, Institute for Myeloma & Bone Cancer Research, Los Angeles, CA, USA; Department of Orthopaedic Surgery, University of California, San Francisco, CA, USA; Division of Radiology, Section of Interventional Neuroradiology, University of Arkansas for Medical Sciences, Little Rock, AR, USA; ; Stem Cell Transplantation & Cellular Therapy Department, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Medical Oncology/Internal Medicine, St Vincent’s Comprehensive Cancer Center, New York, NY, USA; Department of Laboratory Medicine and Pathology, Mayo Clinic, MN, USA; Department of Medical Oncology/Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA; Department of Musculature, Charité der Humboldt Universitàt, Berlin, Germany; Department of Medical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; Department of Orthopaedics, Huntsman Cancer Institute, Salt Lake City, UT, USA; ; Department of Hematology/Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Department of Medical Oncology, Hackensack Cancer Center, Hackensack, NJ, USA; Department of Hematology/Oncology, Cedars-Sinai Outpatient Cancer Center, Los Angeles, CA, USA and Department of Medicine, Division of Hematology-Oncology, Karmanos Cancer Center, Wayne State University School of Medicine, Detroit, MI, USA
منابع مشابه
Study of Multiple Myeloma Occurrence in Patients With 5%-10% Bone Marrow Plasma Cells: A Case Series Regarding Revised IMWG Diagnostic Criteria
Introduction: Utilizing lower limit of bone marrow plasma cells (BMPCs) is the main existing criterion for diagnosis of multiple myeloma (MM). According to the revised international myeloma working group (IMWG) diagnostic criteria, the value of 10% is agreed among experts as the cutoff level for diagnosis. Symptomatic patients with BMPC above this value are identified as definite cases of MM. H...
متن کاملStudy of Multiple Myeloma Occurrence in Patients With 5%-10% Bone Marrow Plasma Cells: A Case Series Regarding Revised IMWG Diagnostic Criteria
Introduction: Utilizing lower limit of bone marrow plasma cells (BMPCs) is the main existing criterion for diagnosis of multiple myeloma (MM). According to the revised international myeloma working group (IMWG) diagnostic criteria, the value of 10% is agreed among experts as the cutoff level for diagnosis. Symptomatic patients with BMPC above this value are identified as definite cases of MM. H...
متن کاملInternational Myeloma Working Group consensus statement regarding the current status of allogeneic stem-cell transplantation for multiple myeloma.
PURPOSE To define consensus statement regarding allogeneic stem-cell transplantation (Allo-SCT) as a treatment option for multiple myeloma (MM) on behalf of International Myeloma Working Group. PATIENTS AND METHODS In this review, results from prospective and retrospective studies of Allo-SCT in MM are summarized. RESULTS Although the introduction of reduced-intensity conditioning (RIC) has...
متن کاملRole of Suppressed Immunoglobulins in Outcome of Patients With Multiple Myeloma
Introduction: Multiple myeloma (MM) is typically presented with abundant monoclonal secretion of one type of immunoglobulin. The other classes of immunoglobulins, which are uninvolved and not secreted by malignant plasma cells, could be decreased. A number of previous studies reported the effect of suppression of uninvolved immunoglobulins on the outcome of patients with myeloma. However, its e...
متن کاملPatient experience of whole body diffusion weighted magnetic resonance imaging (WB-MRI) for staging myeloma
Aim WB-MRI provides a fast, highly sensitive assessment of disease burden in myeloma. The 2015 International Myeloma Working Group consensus statement recommends WB-MRI for staging asymptomatic myeloma and for workup of solitary bone plasmacytoma. The technique is noisy, employs whole body surface coils, and takes longer than a standard MRI spine. We assessed patient experience of WB-MRI and id...
متن کامل